Physician profile
Simon Willis
NPI 1356761191
$7,282.93
in general payments reported to CMS, 2019-2025
13 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,600 · 2020: $1,241 · 2021: $142 · 2023: $2,070 · 2024: $107 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,482 · Food and Beverage: $797 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,482.04 |
| Food and Beverage | $797.17 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,718.75 | 2019-2020 | |
| Medtronic, INC. | $1,973.50 | 2023 | Synchromedii |
| Boston Scientific Corporation | $459.96 | 2019-2025 | General - Pain Management |
| Abbott Laboratories | $317.44 | 2020-2021 | |
| Medtronic USA, INC. | $220.43 | 2019 | |
| Stryker Corporation | $158.83 | 2019 | |
| Merz Pharmaceuticals, LLC | $147.10 | 2023-2025 | Xeomin |
| Tersera Therapeutics LLC | $100.83 | 2019 | |
| Abbvie INC. | $81.37 | 2023-2025 | Botox |
| Biodelivery Sciences International, INC. | $42.20 | 2020 | |
| Forte Bio-Pharma LLC | $32.11 | 2020 | |
| Piramal Critical Care | $15.68 | 2024 | |
| Spr Therapeutics, INC | $14.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.